Psychedelics space has seen some multi-baggers in the span of the last 2 weeks, suggesting investors are once again starting to pour money into speculative shroom stocks.
CSE:LVT is deeply oversold (RSI @ 22.69), hitting all time lows. The company is deeply fundamentally undervalued:
- $1.87M market cap
- Raised $1.5M at 0.20 in February
- Generating revenue of...
Beyond the successful breakout of the stochastic AND the crossover of the MACD, MindMed had a positive earnings report that beat expectations.
All of the pieces are in play for this pattern to play out against expectations - and the break to the upside seems imminent.
You don't have to (and legally shouldn't) listen to me, but I'm sitting happily on my...
Has been a tripp , right? It ain't easy to transition an entire underground movement into a legal bureaucratic compelling business. There's so much potential for these companies.
So let's look at the recent price movement. The DMI shows we reached equilibrium around the mid 4s, if we get a broader market uptrend we'll highly likely see our favorite number 4.20....
Looks like the MACD is still heading down but curling up. RSI is bottoming out as it reaches an important level of support. I think the risk reward at the $28 level is optimal. If you have a high risk tolerance, buy now.
Shrooms are already decriminalized in Denver and are about to be in Detroit.
The TAM which was initially an imaginative number is now becoming...
RSI below 20. Raised $11.5M at $1.07 in January and presents 50% discount at current levels. Good news flow. Psychedelics sector is getting some traction again.
